Eagle Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-270,209
| Closed | -$18.9M | – | 570 |
|
|
2022
Q3 | $18.9M | Buy |
270,209
+1,666
| +0.6% | +$116K | 0.12% | 171 |
|
|
2022
Q2 | $18M | Buy |
268,543
+6,141
| +2% | +$412K | 0.11% | 185 |
|
|
2022
Q1 | $21.6M | Buy |
262,402
+3,594
| +1% | +$295K | 0.11% | 193 |
|
|
2021
Q4 | $38.4M | Sell |
258,808
-698
| -0.3% | -$103K | 0.17% | 166 |
|
|
2021
Q3 | $45.9M | Buy |
+259,506
| New | +$45.9M | 0.21% | 160 |
|
|
2021
Q2 | – | Sell |
-225,534
| Closed | -$40.5M | – | 622 |
|
|
2021
Q1 | $40.5M | Buy |
225,534
+5,563
| +3% | +$1,000K | 0.18% | 179 |
|
|
2020
Q4 | $48.3M | Sell |
219,971
-27,759
| -11% | -$6.1M | 0.27% | 134 |
|
|
2020
Q3 | $41.1M | Sell |
247,730
-27,424
| -10% | -$4.55M | 0.21% | 163 |
|
|
2020
Q2 | $31.6M | Sell |
275,154
-14,334
| -5% | -$1.64M | 0.18% | 178 |
|
|
2020
Q1 | $22.3M | Buy |
289,488
+2,284
| +0.8% | +$176K | 0.14% | 198 |
|
|
2019
Q4 | $37M | Buy |
+287,204
| New | +$37M | 0.18% | 195 |
|